UPDATE: Bristol-Myers Squibb Co. (BMY) PT Raised to $76 at Goldman Sachs
Tweet Send to a Friend
(Updated - February 7, 2022 5:16 AM EST)
Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
